Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.
Eli Lilly and Company announced earlier this week that its popular obesity drug, Zepbound (tirzepatide) outperformed rival ...
It didn’t take long for the shine to come off one of biotech’s recent IPO success stories, with BioAge Labs scrapping a phase ...
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.
The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli Lilly’s popular weight loss medication Zepbound and diabetes drug Mounjaro.
Israel’s war on Gaza – Fatima Bhutto and Dominique de Villepin Fatima Bhutto and former French Prime Minister Dominique de Villepin on the global response to Israel’s war on Gaza. Visitors ...
Stock futures edged lower Monday morning as investors eye this week’s key inflation report. The Consumer Price Index (CPI) ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Skipping school to watch the Super Bowl might pay off for Jordan Petaia, who has quit rugby to scratch his NFL itch. New Zealand's latest prodigy 19-year-old Oli Mathis showed off an unconventional ...